Skip to main navigation Skip to search Skip to main content

Baseline risk factors for QT interval prolongation in patients prescribed IV haloperidol

  • A. J. Muzyk
  • , A. Rayfield
  • , J. Y. Revollo
  • , H. Heinz
  • , J. P. Gagliardi

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
JournalDrug Safety
DOIs
StatePublished - 1800

Disciplines

  • Pharmacy and Pharmaceutical Sciences

Cite this